## **Core Concept**
The question tests the knowledge of antiretroviral drugs used in the treatment of HIV and their potential application or cross-use in treating Hepatitis B virus (HBV) infections. Some antiretroviral drugs have dual activity against both HIV and HBV.

## **Why the Correct Answer is Right**
Tenofovir disoproxil fumarate (TDF) is a nucleotide reverse transcriptase inhibitor (NtRTI) that is effective against both HIV and HBV. It works by inhibiting the reverse transcriptase enzyme of HIV and the polymerase enzyme of HBV, thereby suppressing viral replication. TDF has been used in the treatment of HIV infection and chronic Hepatitis B due to its dual activity.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While some drugs in this class may have activity against HBV, specific mention of drugs and their activity is required for accuracy. Generally, not all drugs in this class have significant activity against HBV.
- **Option B:** This option might represent drugs that are primarily used for HIV but not typically for HBV. Without specifics, it's hard to refute directly, but generally, drugs in other classes like protease inhibitors or non-nucleoside reverse transcriptase inhibitors (NNRTIs) are not primarily used for HBV.
- **Option C:** Similar to Option A, without specifics, it's challenging to directly address, but drugs in other classes may not have the dual activity seen with TDF.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **Tenofovir** is a drug that can be used in the treatment of both HIV and Hepatitis B. It's a part of the antiretroviral therapy regimen for HIV and is also used as a first-line treatment for chronic Hepatitis B due to its efficacy in suppressing HBV replication.

## **Correct Answer:** C. Tenofovir.